Jump Into an All-New Mickey & Friends Adventure with Disney Illusion Island on July 28
9.2.2023 17:00:00 EET | Business Wire | Press release
Embark on a brand-new adventure with Disney Mickey Mouse’s triumphant return to video games – and this time he’s bringing a few friends! Today, Disney, in collaboration with developer Dlala Studios, revealed that Disney Illusion Island , an upcoming local cooperative 2D platform adventure video game for up to four players, will debut exclusively for Nintendo Switch™ on July 28, 2023. Additionally, pre-orders for Disney Illusion Island are available for $39.99 in Nintendo eShop and at retail, beginning today.
“Fans are in for a treat with the upcoming launch of the whimsical cartoon-like experience offered by Disney Illusion Island,” said Luigi Priore, VP, Disney, Pixar and 20th Century Games. “We’re thrilled to work with developer Dlala Studios as they expand upon the Mickey & Friends world with a new and original storyline, engaging gameplay and delightful hand-drawn art style.”
Join Mickey Mouse, Minnie Mouse, Donald Duck and Goofy and set off on a perilous quest to explore the colorfully hand-crafted and yet mysterious island of Monoth in an escapade to recover three magical Tomes – powerful books used to protect the island. Featuring the voice actors of Mickey, Minnie, Donald, and Goofy and an original orchestral score, players can immerse themselves in a solo adventure or team up with up to three friends in local co-op to use special team skills such as Rope Drop, Leap Frog, and a heart gifting Hug to save the island. Discover rich biomes and never-before-seen environments, meet strange yet intriguing characters, and uncover hidden secrets galore!
But the journey will not be easy, and with intrigue afoot, not everything is what it seems on “Illusion Island.”
“Words cannot express how excited we are for players to embrace the Dlala-spin on this brand-new experience for Mickey Mouse, Minnie Mouse, Donald Duck and Goofy,” said AJ Grand-Scrutton, Lead Developer, Dlala Studios. “It has been an incredible honor working on this title and we hope that Nintendo Switch players and Disney fans worldwide love playing it as much as we've loved creating it.”
Disney Illusion Island will be available for $39.99 and will debut worldwide exclusively for Nintendo Switch on July 28, 2023.
For more information about Disney Illusion Island: https://games.disney.com/disney-illusion-island
To watch the latest trailer: https://www.youtube.com/watch?v=Ll9zSkf4Cfw
For Disney Illusion Island assets: https://drive.google.com/drive/folders/1sVurQkkRn_Tq94FDsbBipvWoP3-ssuhe?usp=sharing
For more updates on Disney Illusion Island, please follow us on social below:
About Dlala Studios
Dlala Studios are the creators of Battletoads (2020), and have previously worked on award-winning titles such as Sea of Thieves, The Escapists, and Lost Words: Beyond The Page. The Essex-based studio celebrated their 10th anniversary in 2022, and are currently developing Disney Illusion Island for the Nintendo Switch.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005020/en/
Contact information
MEDIA CONTACT
Disney Consumer Products, Games and Publishing
Dashaun Gasque
Communications Manager
DASHAUN.GASQUE@DISNEY.COM
Dylan Quintero
Senior Specialist, Communications
DYLAN.QUINTERO@DISNEY.COM
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Angel Aligner Unveils Six Innovations for 202711.11.2026 18:23:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bindu Saran, VP of Product Strategy, added: “Angel was founded by orthodontic profe
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 16:58:00 EET | Press release
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gathering of Future Health – A Global Initiative by Abu Dhabi, curated and convened by the Department of Health – Abu Dhabi (DoH) together with Founding Partners PureHealth, M42, Institute for Healthier Living Abu Dhabi (IHLAD) and Mubadala Bio. Held from 20–22 October, the Summit attracted more than 17,300 visitors from 85 countries. It brought together health leaders, researchers, policymakers, investors and inn
De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 16:58:00 EET | Press release
The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par
Starr Chile Assigned A Rating from AM Best11.11.2026 15:30:00 EET | Press release
Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr
Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 15:22:00 EET | Press release
Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an outcome. End customers for Epinal’s SEB include breathalyzer manufacturers, healthcare, mobile computers & clinical smartphones, handheld bio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom